Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma-Reference-Cited by-同舟云学术

Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma

Published:2012-06-29 Issue:9 Volume:14 Page:1136-1145
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Doucette Tiffany A.,Kong Ling-Yuan,Yang Yuhui,Ferguson Sherise D.,Yang Jinbo,Wei Jun,Qiao Wei,Fuller Gregory N.,Bhat Krishna P.,Aldape Kenneth,Priebe Waldemar,Bögler Oliver,Heimberger Amy B.,Rao Ganesh

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/14/9/1136/16663824/nos139.pdf

Reference34 articles.

1. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402;Cairncross;J Clin Oncol,2006

2. Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response;Jaeckle;J Clin Oncol,2006

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial;van den Bent;J Clin Oncol,2006

5. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol,2007

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

2. STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma;Journal of Clinical Investigation;2024-06-17

3. STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC;Frontiers in Molecular Biosciences;2024-06-14

4. Inhibitors of CK2 Kinase for the Treatment of Gliomas and Other Brain Tumors;Acta Poloniae Pharmaceutica - Drug Research;2024-04-09

5. A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy;Small;2024-03-03